Inhalation

INH0426

Issue link: https://www.e-digitaleditions.com/i/1544305

Contents of this Issue

Navigation

Page 10 of 47

Inhalation April 2026 9 Joanne Kilgour, PhD, is Chair of the Association of Inhalation Tox- icologists (AIT) and a Consultant Toxicologist at Mereside Toxicol- ogy Consulting Ltd, Tel: +44 7760 194839, jo.kilgour@apconix.com. Charles J. Knill , PhD, is Co- Membership Secretary & Admin of the Association of Inhalation Tox- icologists (AIT) and an Independent Scientific Consultant based in Liv- erpool, UK, cjk16309@yahoo.co.uk. • In vitro testing and NAMs in inhalation toxicology—publi- cations pending in the Special Edition. Get involved We encourage you to visit the AIT website and LinkedIn page to find opportunities to engage with members and attend a future con- ference. Please contact the AIT at: aitoxicology@gmail.com. Membership Attendance at an AIT conference conveys membership for a period of three years and is renewable with each conference attendance. e AIT currently has more than 180 members. ey have access to an archive of useful information (via the website), including webi- nars, conference slides, posters, photos, annual general meeting (AGM) documents and various useful publications. Publications A list of published AIT papers can be found on the website. In addi- tion, the AIT is currently collabo- rating with Frontiers in Toxicology to publish a special edition of papers based on themes explored at the 2025 AIT conference: www.fron tiersin.org/research-topics/71870/ inhalation-toxicology-trailblazers- charting-a-new-path-to-improve- nams-for-evidence- integration. Workstreams e AIT has several workstreams led by committee members, which aim to increase the AIT's influence (one of our goals) and potentially add to the list of publications con- tributed to or delivered by the AIT. ese include: • Regulatory harmonization with respect to the calculation of safety margins for inhaled tox- icity studies. Members of this team have been instrumental in helping organize a Reagan-Udall Foundation workshop titled, "Advancing Drug Develop- ment by Reducing Reliance on Animal Testing—Case Exam- ple: Preclinical Animal Models in Lung Toxicology" scheduled for February 2026: reaganudall. org/news-and-events/events/ advancing-drug-development- r e d u c i n g - r e l i a n c e - a n i m a l - testing. • Best practice regarding varying of exposure time versus concen- tration to achieve desired doses in inhaled toxicity studies.

Articles in this issue

Links on this page

view archives of Inhalation - INH0426